Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

14

Revenue 2017

Opdivo

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Opdivo was produced by Gilead Sciences.

Merck’s Keytruda significantly extends life in some prostate cancer patients

Merck’s Keytruda significantly extends life in some prostate cancer patients Merck has competition in the area however, with rival from Bristol-Myers Squibb garnering positive results with its double immunotherapy combination PD-1 inhibitor Opdivo (nivolumab) and CTLA4 inhibitor Yervoy (ipilimumab)

Merck’s Keytruda picks up third approval for NSCLC in China

Merck’s Keytruda picks up third approval for NSCLC in China However, it was not the first PD-1 inhibitor to get a green light in the country – Bristol-Myers Squibb won that prize for Opdivo (nivolumab) in NSCLC back in 2018.

Roche’s Tecentriq/Avastin combo improves survival in liver cancer

Roche’s Tecentriq/Avastin combo improves survival in liver cancer HCC could be another important indication for Tecentriq as it plays catch-up in the cancer immunotherapy market with Merck &Co/MSD’s Keytruda (pembrolizumab) and Bristol-Myers Squibb’s Opdivo ... BMS meanwhile reported data a few months ago from the

BMS’ Opdivo/Yervoy combination fails to shine in melanoma

BMS’ Opdivo/Yervoy combination fails to shine in melanoma Bristol-Myers Squibb has faced a bump in the road of its expansion plans for Opdivo/Yervoy, after the combination failed to demonstrate a significant benefit in certain high-risk melanoma ... However, BMS has recently  announced positive results from

MSD’s Keytruda scores another EU okay, in head and neck cancer

MSD’s Keytruda scores another EU okay, in head and neck cancer new treatment option and MSD’s drug another leg up over its rivals in the checkpoint inhibitor category such as Bristol-Myers Squibb’s Opdivo (nivolumab). ... Keytruda also overtakes Opdivo in HNSCC, which at the moment is only approved as a

[ Previous 5 results ] 3 4 5 6 7 8 9 10 11 12 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people...

Latest intelligence

Keep your audiences close
How getting up close and personal with target audiences can fuel creativity...
The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....

Infographics